Advertisement

Soluble components from mesenchymal stromal cell processing exert anti-inflammatory effects and facilitate ischemic muscle regeneration

Published:December 20, 2022DOI:https://doi.org/10.1016/j.jcyt.2022.11.010

      Abstract

      Background aims

      Skeletal muscle regeneration after severe damage is reliant on local stem cell proliferation and differentiation, processes that are tightly regulated by macrophages. Peripheral artery disease is a globally prevalent cardiovascular disease affecting millions of people. Progression of the disease leads to intermittent claudication, subsequent critical limb ischemia and muscle injury. Tissue-derived and ex vivo–expanded mesenchymal stromal cells (MSCs) for skeletal muscle regeneration have been studied, but pre-clinical and clinical results have not been consistent. As a result, the potential therapeutic efficacy and associated repair mechanisms of MSCs remain unclear. Numerous studies have demonstrated the vulnerability of delivered MSCs, with a precipitous drop in cell viability upon transplantation. This has prompted investigation into the therapeutic benefit of apoptotic cells, microvesicles, exosomes and soluble signals that are released upon cell death.

      Methods

      In this study, we characterized various components produced by MSCs after cell death induction under different conditions. We discovered anti-inflammatory and pro-regenerative effects produced by cell components following a freeze and thaw (F&T) process on macrophage polarization in vitro. We further investigated the underlying mechanisms of macrophage polarization by those components resulting from severe cell death induction.

      Results

      We found potent therapeutic effects from F&T-induced cell debris are dependent on the externalization of phosphatidylserine on the plasma membrane. In contrast, effects from the supernatant of F&T-induced cell death primarily depends on the released protein content. We then applied the F&T-induced cell supernatant to an animal model of peripheral artery disease to treat muscle injury caused by severe ischemia. Treatment with the F&T supernatant but not the vulnerable MSCs resulted in significantly improved recovery of muscle function, blood flow and morphology and inflammation resolution in the affected muscles 2 weeks after injury.

      Conclusions

      This study validates the therapeutic potential of F&T-induced supernatant obviating the need for a viable population from vulnerable MSCs to treat injury, thus providing a roadmap for cell-free therapeutic approaches for tissue regeneration.

      Graphical Abstract

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kullo IJ
        • Rooke TW.
        Clinical Practice. Peripheral artery disease.
        N Engl J Med. 2016; 374: 861-871https://doi.org/10.1056/NEJMcp1507631
        • Virani SS
        • Alonso A
        • Aparicio HJ
        • et al.
        Heart disease and stroke statistics-2021 update: a report from the American Heart Association.
        Circulation. 2021; 143: e254-e743https://doi.org/10.1161/CIR.0000000000000950
        • Tidball JG.
        Mechanisms of muscle injury, repair, and regeneration.
        Compr Physiol. 2011; 1: 2029-2062https://doi.org/10.1002/cphy.c100092
        • Hammers DW
        • Rybalko V
        • Merscham-Banda M
        • Hsieh PL
        • Suggs LJ
        • Farrar RP.
        Anti-inflammatory macrophages improve skeletal muscle recovery from ischemia-reperfusion.
        J Appl Physiol (1985). 2015; 118: 1067-1074https://doi.org/10.1152/japplphysiol.00313.2014
        • Rybalko V
        • Hsieh PL
        • Ricles LM
        • Chung E
        • Farrar RP
        • Suggs LJ.
        Therapeutic potential of adipose-derived stem cells and macrophages for ischemic skeletal muscle repair.
        Regen Med. 2017; 12: 153-167https://doi.org/10.2217/rme-2016-0094
        • Hamidian Jahromi S
        • Davies JE
        Concise review: skeletal muscle as a delivery route for mesenchymal stromal cells.
        Stem Cells Transl Med. 2019; 8: 456-465https://doi.org/10.1002/sctm.18-0208
        • Song N
        • Scholtemeijer M
        • Shah K.
        Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential.
        Trends Pharmacol Sci. 2020; 41: 653-664https://doi.org/10.1016/j.tips.2020.06.009
        • Wakitani S
        • Saito T
        • Caplan AI.
        Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine.
        Muscle Nerve. 1995; 18: 1417-1426https://doi.org/10.1002/mus.880181212
        • Liang X
        • Ding Y
        • Zhang Y
        • Tse HF
        • Lian Q.
        Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.
        Cell Transplant. 2014; 23: 1045-1059https://doi.org/10.3727/096368913×667709
        • Ricles LM
        • Hsieh PL
        • Dana N
        • et al.
        Therapeutic assessment of mesenchymal stem cells delivered within a PEGylated fibrin gel following an ischemic injury.
        Biomaterials. 2016; 102: 9-19https://doi.org/10.1016/j.biomaterials.2016.06.011
        • Dhada KS
        • Hernandez DS
        • Suggs LJ.
        In vivo photoacoustic tracking of mesenchymal stem cell viability.
        ACS Nano. 2019; 13: 7791-7799https://doi.org/10.1021/acsnano.9b01802
        • Preda MB
        • Neculachi CA
        • Fenyo IM
        • et al.
        Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice.
        Cell Death Dis. 2021; 12 (Published 2021 Jun 2): 566https://doi.org/10.1038/s41419-021-03839-w
        • Galleu A
        • Riffo-Vasquez Y
        • Trento C
        • et al.
        Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.
        Sci Transl Med. 2017; 9: eaam7828https://doi.org/10.1126/scitranslmed.aam7828
        • Pang SHM
        • D'Rozario J
        • Mendonca S
        • et al.
        Mesenchymal stromal cell apoptosis is required for their therapeutic function.
        Nat Commun. 2021; 12 (Published 2021 Nov 11): 6495https://doi.org/10.1038/s41467-021-26834-3
        • He X
        • Hong W
        • Yang J
        • et al.
        Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine [published correction appears in Signal Transduct Target Ther. 2022 Jan 13;7(1):13].
        Signal Transduct Target Ther. 2021; 6 (Published 2021 Jul 14): 270https://doi.org/10.1038/s41392-021-00688-z
        • Fadok VA
        • Voelker DR
        • Campbell PA
        • Cohen JJ
        • Bratton DL
        • Henson PM.
        Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.
        J Immunol. 1992; 148: 2207-2216
        • Fadok VA
        • Bratton DL
        • Konowal A
        • Freed PW
        • Westcott JY
        • Henson PM.
        Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
        J Clin Invest. 1998; 101: 890-898https://doi.org/10.1172/JCI1112
        • Ghahremani Piraghaj M
        • Soudi S
        • Ghanbarian H
        • Bolandi Z
        • Namaki S
        • Hashemi SM
        Effect of efferocytosis of apoptotic mesenchymal stem cells (MSCs) on C57BL/6 peritoneal macrophages function.
        Life Sci. 2018; 212: 203-212https://doi.org/10.1016/j.lfs.2018.09.052
        • Dhada KS
        • Hernandez DS
        • Huang W
        • Suggs LJ.
        Gold nanorods as photoacoustic nanoprobes to detect pro-inflammatory macrophages and inflammation.
        ACS Appl Nano Mater. 2020; (Published online June 26)https://doi.org/10.1021/acsanm.0c01324
        • Demchenko AP.
        Beyond annexin V: fluorescence response of cellular membranes to apoptosis.
        Cytotechnology. 2013; 65: 157-172https://doi.org/10.1007/s10616-012-9481-y
        • Li X
        • Shang B
        • Li YN
        • Shi Y
        • Shao C.
        IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide.
        Stem Cell Res Ther. 2019; 10 (Published 2019 Jan 11): 18https://doi.org/10.1186/s13287-018-1102-z
        • Beyer C
        • Stearns NA
        • Giessl A
        • Distler JH
        • Schett G
        • Pisetsky DS.
        The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death.
        Innate Immun. 2012; 18: 727-737https://doi.org/10.1177/1753425912437981
        • Cheng M
        • Nguyen MH
        • Fantuzzi G
        • Koh TJ.
        Endogenous interferon-gamma is required for efficient skeletal muscle regeneration.
        Am J Physiol Cell Physiol. 2008; 294: C1183-C1191https://doi.org/10.1152/ajpcell.00568.2007
        • Wang WZ
        • Fang XH
        • Stephenson LL
        • Khiabani KT
        • Zamboni WA.
        Ischemia/reperfusion-induced necrosis and apoptosis in the cells isolated from rat skeletal muscle.
        J Orthop Res. 2008; 26: 351-356https://doi.org/10.1002/jor.20493
        • Cowled PA
        • Leonardos L
        • Millard SH
        • Fitridge RA.
        Apoptotic cell death makes a minor contribution to reperfusion injury in skeletal muscle in the rat.
        Eur J Vasc Endovasc Surg. 2001; 21: 28-34https://doi.org/10.1053/ejvs.2000.1209
        • Knight KR
        • Messina A
        • Hurley JV
        • Zhang B
        • Morrison WA
        • Stewart AG.
        Muscle cells become necrotic rather than apoptotic during reperfusion of ischaemic skeletal muscle.
        Int J Exp Pathol. 1999; 80: 169-175https://doi.org/10.1046/j.1365-2613.1999.00111.x
        • Cesari M
        • Pahor M
        • Incalzi RA.
        Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.
        Cardiovasc Ther. 2010; 28: e72-e91https://doi.org/10.1111/j.1755-5922.2010.00171.x
        • Kubala MH
        • Punj V
        • Placencio-Hickok VR
        • et al.
        Plasminogen activator inhibitor-1 promotes the recruitment and polarization of macrophages in Cancer.
        Cell Rep. 2018; 25 (e7): 2177-2191https://doi.org/10.1016/j.celrep.2018.10.082
        • Verreck FA
        • de Boer T
        • Langenberg DM
        • et al.
        Human IL-23–producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.
        Proc Natl Acad Sci U S A. 2004; 101: 4560-4565https://doi.org/10.1073/pnas.0400983101
        • Fadok VA
        • Bratton DL
        • Guthrie L
        • Henson PM.
        Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases.
        J Immunol. 2001; 166: 6847-6854https://doi.org/10.4049/jimmunol.166.11.6847
        • Penny HL
        • Sieow JL
        • Adriani G
        • et al.
        Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma.
        Oncoimmunology. 2016; 5 (Published 2016 Jun 21)e1191731https://doi.org/10.1080/2162402X.2016.1191731
        • Baroja-Mazo A
        • Martín-Sánchez F
        • Gomez AI
        • et al.
        The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response.
        Nat Immunol. 2014; 15: 738-748https://doi.org/10.1038/ni.2919
        • Harris HE
        • Andersson U
        • Pisetsky DS.
        HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.
        Nat Rev Rheumatol. 2012; 8 (Published 2012 Jan 31): 195-202https://doi.org/10.1038/nrrheum.2011.222
        • Riley JS
        • Tait SW.
        Mitochondrial DNA in inflammation and immunity.
        EMBO Rep. 2020; 21: e49799https://doi.org/10.15252/embr.201949799
        • Nakamura Y
        • Miyaki S
        • Ishitobi H
        • et al.
        Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration.
        FEBS Lett. 2015; 589: 1257-1265https://doi.org/10.1016/j.febslet.2015.03.031
        • Lai RC
        • Arslan F
        • Lee MM
        • et al.
        Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.
        Stem Cell Res. 2010; 4: 214-222https://doi.org/10.1016/j.scr.2009.12.003
        • Liu J
        • Qiu X
        • Lv Y
        • et al.
        Apoptotic bodies derived from mesenchymal stem cells promote cutaneous wound healing via regulating the functions of macrophages.
        Stem Cell Res Ther. 2020; 11 (Published 2020 Nov 27): 507https://doi.org/10.1186/s13287-020-02014-w
        • Gonçalves FDC
        • Luk F
        • Korevaar SS
        • et al.
        Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes.
        Sci Rep. 2017; 7 (Published 2017 Sep 21): 12100https://doi.org/10.1038/s41598-017-12121-z
        • Mitchell R
        • Mellows B
        • Sheard J
        • et al.
        Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins.
        Stem Cell Res Ther. 2019; 10 (Published 2019 Apr 5): 116https://doi.org/10.1186/s13287-019-1213-1
        • Szondy Z
        • Sarang Z
        • Kiss B
        • Garabuczi É
        • Köröskényi K.
        Anti-inflammatory mechanisms triggered by apoptotic cells during their clearance.
        Front Immunol. 2017; 8 (Published 2017 Aug 2): 909https://doi.org/10.3389/fimmu.2017.00909
        • Li T
        • Zhang Z
        • Bartolacci JG
        • et al.
        Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection.
        J Clin Invest. 2020; 130: 5397-5412https://doi.org/10.1172/JCI133008
        • Kuswanto W
        • Burzyn D
        • Panduro M
        • et al.
        Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells.
        Immunity. 2016; 44: 355-367https://doi.org/10.1016/j.immuni.2016.01.009
        • Kraynak CA
        • Yan DJ
        • Suggs LJ
        Modulating inflammatory macrophages with an apoptotic body-inspired nanoparticle.
        Acta Biomater. 2020; (S1742706120301823)https://doi.org/10.1016/j.actbio.2020.03.041
        • Kraynak CA
        • Huang W
        • Bender EC
        • Wang J-L
        • Hanafy MS
        • Cui Z
        • Suggs LJ
        Apoptotic body-inspired nanoparticles target macrophages at sites of inflammation to support an anti-inflammatory phenotype shift.
        Int J Pharma. 2022; 618121634https://doi.org/10.1016/j.ijpharm.2022.121634